Valneva
Pre-clinicalValneva is a specialty vaccine company focused on the development, manufacturing and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.
Founded
2013
Focus
AntibodiesBiologicsVaccines
About
Valneva is a specialty vaccine company focused on the development, manufacturing and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need.
Funding History
4Total raised: $219.6M
PIPE$107MUndisclosedMay 15, 2021
Grant$2.6MCEPIMar 15, 2020
Series D$110MBpifranceJun 15, 2018
IPOUndisclosedUndisclosedSep 15, 2013
Company Info
TypePrivate
Founded2013
LocationVienna, Austria
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
AlgOss Biotechnologies
Pre-clinical · Graz
Angios Biotech
Pre-clinical ·
F4 Pharma
Pre-clinical · Vienna
aTENSION.life
Pre-clinical · Vienna
Austrianni
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile